开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究 经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]

2022-01-06 emmawang

偏重的研究方向：临床研究
经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊

110 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究 经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]

2021-12-01 emmawang

偏重的研究方向：临床研究
经验分享：投稿8天，在等待中

175 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究 经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]

2022-01-04 药剂学萌新

被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭

115 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究 经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]

2021-12-27 rayms

评审和期刊编辑要求我补实验，就一定要补么，不补行不行？

122 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究 经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]

2021-12-29 msSSSSSD

对于审稿人好的意见也要回复么？

124 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究 经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]

2020-05-21 榴莲味少女

最近有没有接收的朋友。。我投稿一个月了一点消息都没有

239 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究 经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]

2021-12-29 药剂学萌新

偏重的研究方向：药动学
经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊

158 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究 经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]

2021-11-26 1471ca3am71暂无昵称

一篇综述投了9天后让转投其他专业期刊

128 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究 经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]

2019-10-07 1e0e201bm72(暂无匿称)

有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span

209 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1181162, encodeId=8b8e1181162ad, content=偏重的研究方向：临床研究 经验分享：投稿一个半月了，一点消息也没有，是否要发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Thu Jan 06 08:20:54 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075746, encodeId=845610e574689, content=偏重的研究方向：临床研究 经验分享：投稿8天，在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb368368, createdName=emmawang, createdTime=Wed Dec 01 08:56:39 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180279, encodeId=d2f911802e92d, content=被拒稿了，大家还有什么期刊推荐吗？关于药剂学的😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Tue Jan 04 08:47:08 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096775, encodeId=de4e1096e752d, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096776, encodeId=e94c1096e76d8, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591429, encodeId=20e659142995, content=最近有没有接收的朋友。。我投稿一个月了一点消息都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085362, encodeId=cd751085362c9, content=偏重的研究方向：药动学 经验分享：大家好，我投稿快四个月了，状态一直在under review，我是不是应该去催一下啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/cac3cee8232546d78d35f506c70f6218/fd5100ed3c184c9eae1a60c7e9329662.jpg, createdBy=2edd5536784, createdName=药剂学萌新, createdTime=Wed Dec 29 09:58:25 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074269, encodeId=373e10e4269ec, content=一篇综述投了9天后让转投其他专业期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed3e5192291, createdName=1471ca3am71暂无昵称, createdTime=Fri Nov 26 16:23:26 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577429, encodeId=67025e742977, content=有修回过程嘛spanclassquote182vsoH8609暂无昵称20190915发表br研究方向药理心血管药理学接收率约75审稿时间约1个月8月11号投的文章9月10号杂志社直接决定接收文章个人认为杂志的要求不高但是一定要按照杂志社的要求上传手稿span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34f1937121, createdName=1e0e201bm72(暂无匿称), createdTime=Mon Oct 07 20:36:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601755, encodeId=ab46601e557d, content=请问有没有接收的朋友知道怎么汇出版费？我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ia14wziafLzcAeZ4vYxdTeBibHZ8fp8oSmRkbaMRXlHLQnqq15v5ACJZzGkcb1MHr89mzms77P8P4KkExXaxc3jUQ/132, createdBy=508d2440943, createdName=榴莲味少女, createdTime=Sun Jun 07 17:10:25 CST 2020, time=2020-06-07, status=1, ipAttribution=)]

2020-06-07 榴莲味少女

请问有没有接收的朋友知道怎么汇出版费？我是通过境外**转账汇过去的，但是不知道怎么通知编辑部我已经汇款了。。

175 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务